{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:57:58Z","timestamp":1774115878721,"version":"3.50.1"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.2169\/internalmedicine.3216-19","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T22:03:35Z","timestamp":1571263415000},"page":"429-433","source":"Crossref","is-referenced-by-count":9,"title":["Pulmonary Intravascular Large B-cell Lymphoma in a Patient Administered Methotrexate for Rheumatoid Arthritis"],"prefix":"10.2169","volume":"59","author":[{"given":"Eri","family":"Iwami","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumimaro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Sasahara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoi","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsu","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Terashima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Conway R, Low C, Coughlan RJ, O'Donnell MJ, Carey JJ. Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheum 66: 803-812, 2014."},{"key":"2","unstructured":"2. Thaniyan A, Ayman FFA, Mirghani HO, Al-Sayed BA, Merghani TH. Histopathological features of methotrexate induced pulmonary lesions in rheumatoid arthritis patients: a systematic review of case reports. Open Access Maced J Med Sci 5: 266-270, 2017."},{"key":"3","unstructured":"3. Hoshida Y, Xu J-X, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322-331, 2007."},{"key":"4","unstructured":"4. Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91: 20-28, 2013."},{"key":"5","unstructured":"5. Inui Y, Matsuoka H, Yakushijin K, et al. Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leuk Lymphoma 56: 3045-3051, 2015."},{"key":"6","unstructured":"6. Harigai M. Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: a review of the literature and current perspective. Mod Rheumatol 28: 1-8, 2018."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tokuhira M, Saito S, Okuyama A, et al. Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression. Leuk Lymphoma 59: 1143-1152, 2018.","DOI":"10.1080\/10428194.2017.1369073"},{"key":"8","unstructured":"8. Gion Y, Iwaki N, Takata K, et al. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci 108: 1271-1280, 2017."},{"key":"9","unstructured":"9. Kurita D, Miyoshi H, Ichikawa A, et al. Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors. Am J Surg Pathol 43: 869-884, 2019."},{"key":"10","unstructured":"10. Ponzoni M, Ferreri AJM, Campo E, et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol 25: 3168-3173, 2007."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kikuchi J, Kaneko Y, Kasahara H, et al. Methotrexate-associated intravascular large B-cell lymphoma in a patient with rheumatoid arthritis. Intern Med 55: 1661-1665, 2016.","DOI":"10.2169\/internalmedicine.55.6943"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kida T, Kohno M, Chinen Y, et al. Intravascular lymphoma in a rheumatoid arthritis patient following short-term methotrexate treatment. Rheumatology 56: 318-320, 2017.","DOI":"10.1093\/rheumatology\/kew414"},{"key":"13","unstructured":"13. Hagihara M, Mese T, Ohara S, Hua J, Ide S, Inoue M. Methotrexate-associated intravascular large B-cell lymphoma in a patient with rheumatoid arthritis: a very rare case. Intern Med 57: 3001-3005, 2018."},{"key":"14","unstructured":"14. Gaulard P, Swerdlow SH, Harris NL, Sundstrom C, Jaffe ES. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. IARC, Lyon, France, 2017: 462-464."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hare SS, Souza CA, Bain G, Seely JM, Gomes MM, Quigley M. The radiological spectrum of pulmonary lymphoproliferative disease. Br J Radiol 85: 848-864, 2012.","DOI":"10.1259\/bjr\/16420165"},{"key":"16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lungcan.2019.04.004","volume":"132","author":"M-C Zhang","year":"2019","unstructured":"16. Zhang M-C, Zhou M, Song Q, et al. Clinical features and outcomes of pulmonary lymphoma: a single center experience of 180 cases. Lung Cancer 132: 39-44, 2019.","journal-title":"Lung Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chen Y, Chen A, Jiang H, et al. HRCT in primary pulmonary lymphoma: can CT imaging phenotypes differentiate histological subtypes between mucosa-associated lymphoid tissue (MALT) lymphoma and non-MALT lymphoma? J Thorac Dis 10: 6040-6049, 2018.","DOI":"10.21037\/jtd.2018.10.63"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shimada K, Kinoshita T, Naoe T, Nakamura S. Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol 10: 895-902, 2009.","DOI":"10.1016\/S1470-2045(09)70140-8"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Cha MJ, Lee KS, Hwang HS, et al. Pulmonary intravascular lymphomatosis: clinical, CT, and PET findings, correlation of CT and pathologic results, and survival outcome. Radiology 280: 602-610, 2016.","DOI":"10.1148\/radiol.2016151706"},{"key":"20","unstructured":"20. Zhang Y, Bi L, Qiu Y, et al. Primary pulmonary intravascular large B-cell lymphoma: a report of three cases and literature review. Oncol Lett 15: 3610-3613, 2018."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Martusewicz-Boros M, Wiatr E, Radzikowska E, Roszkowski-Sliz K, Langfort R. Pulmonary intravascular large B-cell lymphoma as a cause of severe hypoxemia. J Clin Oncol 25: 2137-2139, 2007.","DOI":"10.1200\/JCO.2007.10.7201"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Choi EJ, Jin GY, Chung MJ. Serial chest CT findings of intravascular large B-cell lymphoma of the lungs. J Thorac Dis 10: E218-E220, 2018.","DOI":"10.21037\/jtd.2018.02.44"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Souza CA, Quan K, Seely J, Kravcik S, Burns B. Pulmonary intravascular lymphoma. J Thorac Imaging 24: 231-233, 2009.","DOI":"10.1097\/RTI.0b013e31819724d9"},{"key":"24","unstructured":"24. Rajyaguru DJ, Bhaskar C, Borgert AJ, Smith A, Parsons B. Intravascular large B-cell lymphoma in the United states (US): a population-based study using surveillance, epidemiology, and end results program and national cancer database. Leuk Lymphoma 58: 2080-2088, 2017."},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Saito S, Kaneko Y, Yamaoka K, Tokuhira M, Takeuchi T. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate. Rheumatology 56: 940-946, 2017.","DOI":"10.1093\/rheumatology\/kex002"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/3\/59_3216-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T03:43:31Z","timestamp":1580528611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/3\/59_3216-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3216-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}